Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Musculoskeletal Pain and Right Leg Paresthesia Revealed as Large Ovarian Mucinous Cystadenoma: A Case Report.
Am J Case Rep
September 2024
Obstetrics and Gynecology Clinic, K.M.P THERAPIS Paphos Medical Center, Paphos, Cyprus.
Article Synopsis
- * Small ovarian cystadenomas are often asymptomatic but can cause discomfort and other symptoms as they grow, including abdominal pain and urinary issues.
- * A case study of a 31-year-old woman highlights how a large mucinous cystadenoma in the sacrococcygeal area can be mistaken for musculoskeletal issues, underscoring the need for early diagnosis to ensure proper treatment and symptom relief.
Gynecomastia in a Man With Adrenal Mass.
JCEM Case Rep
January 2024
Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
Estrogen-secreting adrenocortical carcinoma (ACC) is exceedingly rare, representing 1% to 2% of all ACCs. We present a case of a 65-year-old man diagnosed with an estrogen-secreting, 4.3-cm right adrenal mass discovered during work-up for bilateral gynecomastia.
View Article and Find Full Text PDFOverview of the 2022 WHO Classification of Adrenal Cortical Tumors.
Endocr Pathol
March 2022
Department of Oncology, University of Turin, Turin, Italy.
The new WHO classification of adrenal cortical proliferations reflects translational advances in the fields of endocrine pathology, oncology and molecular biology. By adopting a question-answer framework, this review highlights advances in knowledge of histological features, ancillary studies, and associated genetic findings that increase the understanding of the adrenal cortex pathologies that are now reflected in the 2022 WHO classification. The pathological correlates of adrenal cortical proliferations include diffuse adrenal cortical hyperplasia, adrenal cortical nodular disease, adrenal cortical adenomas and adrenal cortical carcinomas.
View Article and Find Full Text PDFFeminizing adrenal tumor identified by plasma steroid profiling.
Endocrinol Diabetes Metab Case Rep
November 2021
Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Summary: Feminizing estrogen-secreting adrenocortical carcinomas (ACCs) are exceedingly rare and carry a poor prognosis. The most common presenting trait is gynecomastia, but enlarged breasts are also a frequent clinical finding in healthy men. Biochemical evaluation may be challenging.
View Article and Find Full Text PDFFeminizing Adrenocortical Tumors as a Rare Etiology of Isosexual/Contrasexual Pseudopuberty.
J Clin Res Pediatr Endocrinol
March 2022
Hacettepe University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology, Ankara, Turkey
Objective: Estrogen-secreting adrenocortical tumors (ACTs) are quite rare with feminizing adrenocortical tumors (FATs) accounting for 0.37-2% of all ACTs. The aim was to evaluate clinical and hormonal characteristics of FATS as well as treatment options and follow-up in the pediatric age group.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!